AnalystsMathew Blackman
Mathew Blackman's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 16%
#768 out of 4878 analysts
Average Return
+13.44%
Win Rate
55%23 out of 42
Risk vs Reward
Poor
Good

Mathew Blackman's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Adapthealth CorpAHCO
+188.39%$13.27$38.27
2020-01-30 -
2021-01-29
Strong Buy
Dexcom IncDXCM
+180.62%$36.62$102.75
2019-10-22 -
2020-10-23
Strong Buy
Clearpoint Neuro IncCLPT
+129.72%$5.35$12.29
2023-10-23 -
2024-10-23
Strong Buy
Alphatec Holdings IncATEC
+91.87%$6.64$12.74
2024-07-31 -
2025-05-14
Strong Buy
Dexcom IncDXCM
+85.58%$48.68$90.33
2019-11-06 -
2020-11-06
Strong Buy

Mathew Blackman's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Inogen IncINGN
6Hold$7.00+19.05%Maintains
7 days ago
Tandem Diabetes Care IncTNDM
5Strong Buy$31.00+35.67%Maintains
14 days ago
Penumbra IncPEN
2Strong Buy$318.00+10.05%Maintains
21 days ago
Clearpoint Neuro IncCLPT
3Strong Buy$25.00+101.13%Maintains
a month ago
Beta Bionics IncBBNX
1Strong Buy$25.00+94.70%Initiates Coverage On
3 months ago
Insulet CorpPODD
3Hold$293.00-8.84%Maintains
3 months ago
Globus Medical IncGMED
6Strong Buy$94.00+61.60%Maintains
3 months ago
Orthofix Medical IncOFIX
5Strong Buy$24.00+100.50%Upgrades
6 months ago
Cerus CorpCERS
1Strong Buy$3.00+140.00%Maintains
7 months ago
Inari Medical IncNARI
1Hold$50.00-37.48%Initiates Coverage On
8 months ago
Dexcom IncDXCM
11Strong Buy$100.00+15.58%Maintains
9 months ago
Alphatec Holdings IncATEC
5Strong Buy$16.00+25.59%Maintains
9 months ago
Adapthealth CorpAHCO
2Hold$11.00N/ADowngrades
2 years ago
Apollo Endosurgery IncAPEN
3Hold$10.00N/ADowngrades
2 years ago
Seaspine Holdings CorpSPNE
1Strong Buy$22.00N/AInitiates Coverage On
5 years ago
Nuvasive IncNUVA
1Strong Buy$64.00N/AInitiates Coverage On
5 years ago
Wright Medical Group NvWMGI
2Hold$30.00N/ADowngrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.